1-(4-Methylbenzyl)piperazine - CAS 23173-57-1
Catalog: |
BB017969 |
Product Name: |
1-(4-Methylbenzyl)piperazine |
CAS: |
23173-57-1 |
Synonyms: |
Piperazine, 1-[(4-methylphenyl)methyl]-; Piperazine, 1-(p-methylbenzyl)-; 1-(p-Methylbenzyl)piperazine; 1-(p-Tolylmethyl)piperazine; N-(p-Methylbenzyl)piperazine |
Related CAS: | 435345-17-8 (monohydrochloride)
|
IUPAC Name: | 1-[(4-methylphenyl)methyl]piperazine |
Description: | 1-(4-Methylbenzyl)piperazine, a metabolite of Meclizine, is a useful synthetic intermediate in the synthesis of 3-Desmethyl 4-Methyl Meclizine Dihydrochloride. |
Molecular Weight: | 190.28 |
Molecular Formula: | C12H18N2 |
Canonical SMILES: | CC1=CC=C(C=C1)CN2CCNCC2 |
InChI: | InChI=1S/C12H18N2/c1-11-2-4-12(5-3-11)10-14-8-6-13-7-9-14/h2-5,13H,6-10H2,1H3 |
InChI Key: | RNAXUUAJNMDESG-UHFFFAOYSA-N |
Boiling Point: | 120-121°C |
Melting Point: | 36-37°C |
Purity: | 95% |
Density: | 1.011±0.06 g/cm3 |
Appearance: | Low-melting Solid |
Storage: | Store at RT |
MDL: | MFCD01075235 |
LogP: | 1.66690 |
GHS Hazard Statement: | H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation] |
Precautionary Statement: | P261, P264, P271, P280, P302+P352, P304+P340, P305+P351+P338, P310, P312, P321, P332+P313, P362, P403+P233, P405, and P501 |
Signal Word: | Danger |
Publication Number | Title | Priority Date |
CN-113214275-A | Pyranocarbazole alkaloid derivatives and their use for treating nervous system diseases | 20200204 |
WO-2021077010-A1 | Bifunctional molecules containing an e3 ubiquitine ligase binding moiety linked to a bcl6 targeting moiety | 20191017 |
CN-110615774-A | Benzyl piperazine compound with anti-inflammatory activity, preparation method and medical application | 20190919 |
WO-2020210377-A1 | Heterocyclic compounds and uses thereof | 20190409 |
WO-2020205967-A1 | Polymorphs of a kinase inhibitor, pharmaceutical compositions containing such a compound, preparation methods, and applications | 20190402 |
Complexity: | 156 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 190.146998583 |
Formal Charge: | 0 |
Heavy Atom Count: | 14 |
Hydrogen Bond Acceptor Count: | 2 |
Hydrogen Bond Donor Count: | 1 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 190.146998583 |
Rotatable Bond Count: | 2 |
Topological Polar Surface Area: | 15.3 Å2 |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | 1.5 |
-
Catalog: BB052624
(2-Fluorophenyl)-piperazin-1-ylmethanone 2,2,2-trifluoroacetic acid
Detail
-
Catalog: BB024422
(2S,6S)-2,6-Dimethylpiperazine
Detail
-
Catalog: BB011156
(±)-trans-1-Allyl-2,5-dimethylpiperazine
Detail
-
Catalog: BB078849
((2S,4S)-1-benzyl-4-((tert-butyldimethylsilyl)oxy)pyrrolidin-2-yl)methanol
Detail
-
Catalog: BB078843
(2R,5R)-1,2,5-trimethylpiperazine dihydrochloride
Detail
-
Catalog: BB077946
(2S,5R)-5-Ethyl-2-methyl-1-tosylpiperazine
Detail
-
Catalog: BB079235
(2R,5R)-tert-Butyl 5-(hydroxymethyl)-2-methylpiperazine-1-carboxylate
Detail
-
Catalog: BB000557
((1-[(4-Methyl-1-piperazinyl)methyl]cyclopropyl)methyl)amine
Detail
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Piperazines
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS